Figures & data
Figure 1 Patient screening process.
![Figure 1 Patient screening process.](/cms/asset/7269bfdd-9b4d-4e42-8c2c-9cbb548469c9/dcia_a_209428_f0001_b.jpg)
Table 1 Characteristics of patients older than 65 years included in the study
Table 2 Logistic regression analysis of characteristics for PSS in elderly patients (≥65 years)
Table 3 Multivariate regression analysis of characteristics for survival in elderly patients (≥65 years) before PSM
Table 4 Multivariate regression analysis of characteristics for survival in elderly patients (: Multfter PSM)
Figure 2 Overall survival and cancer-specific survival in elderly patients (≥65 years) with metastatic pNET who underwent primary site surgery (PSS) and no primary site surgery (NPSS), before and after propensity score matching (PSM).
![Figure 2 Overall survival and cancer-specific survival in elderly patients (≥65 years) with metastatic pNET who underwent primary site surgery (PSS) and no primary site surgery (NPSS), before and after propensity score matching (PSM).](/cms/asset/fbcadffa-f867-4b9d-acad-5d0d635bfb83/dcia_a_209428_f0002_c.jpg)
Figure 3 Kaplan–Meier analysis of cancer-specific survival for elderly patients (≥65 years) in sub-groups.
![Figure 3 Kaplan–Meier analysis of cancer-specific survival for elderly patients (≥65 years) in sub-groups.](/cms/asset/73ea3980-9f3b-49f9-bcbb-a006b39d2d41/dcia_a_209428_f0003_c.jpg)
Table S1 Multivariate regression analysis of characteristics for cancer-specific survival in patients with age 65–74 years+ well or moderately differentiated
Table S2 Multivariate regression analysis of characteristics for cancer-specific survival in patients with age ≥75 years+ well or moderately differentiated
Table S3 Multivariate regression analysis of characteristics for cancer-specific survival in patients with age 65–74 years+ poorly differentiated or undifferentiated
Table S4 Multivariate regression analysis of characteristics for cancer-specific survival in patients with age ≥75 years+ poorly differentiated or undifferentiated